Search Within

Joachim Yahalom

  1. "Lymphoma"
Formats
  1. Meeting Abstract (95)
  2. Journal Article (88)
  3. Book Section (17)
  4. Research Letter (3)
  5. Conference Paper (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (205)
  2. Department of Medicine (205)
  3. Hematologic Malignancies, Division of (205)
  4. Lymphoma (205)
  5. Radiation Oncology, Department of (205)
  6. Survivorship Research (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. David Straus (82)
  3. Ariela Noy (71)
  4. Craig Moskowitz (71)
  5. Steven Horwitz (65)
  6. Maria Palomba (63)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (20)
  4. 2022 (7)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Blood (65)
  2. Hematological Oncology (15)
  3. Journal of Clinical Oncology (15)
  4. International Journal of Radiation Oncology, Biology, Physics (14)
  5. Journal of the National Comprehensive Cancer Network (14)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (73)
  2. Elsevier Inc. (25)
  3. Wiley Blackwell (18)
  4. American Society of Clinical Oncology (15)
  5. Harborside Press (14)
  6. John Wiley & Sons (9)

More Publishers

Results (205)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
    Journal Article

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
    Meeting Abstract

    Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save